Piper Jaffray Initiates Meridian Bioscience At Underweight, $14 PT

Symbols: VIVO
Share

Piper Jaffray has initiated Meridian Bioscience (NASDAQ: VIVO) with an Underweight rating and $14 price target.


 
 
< Previous
Jefferies Downgrades NetLogic Microsystems To Hold, Raises PT To $50
Next >
Piper Jaffray Initiates Internap Network Services At Overweight, $6.50 PT
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust